Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · Real-Time Price · USD
7.60
+0.27 (3.68%)
At close: Aug 13, 2025, 4:00 PM
7.60
0.00 (0.00%)
Pre-market: Aug 14, 2025, 8:15 AM EDT
Trevi Therapeutics Employees
Trevi Therapeutics had 26 employees as of December 31, 2024. The number of employees increased by 1 or 4.00% compared to the previous year.
Employees
26
Change (1Y)
1
Growth (1Y)
4.00%
Revenue / Employee
n/a
Profits / Employee
-$1,819,154
Market Cap
925.50M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
TRVI News
- 5 days ago - Trevi Therapeutics, Inc. (TRVI) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 6 days ago - Trevi Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Updates - PRNewsWire
- 13 days ago - Trevi Therapeutics to Report Second Quarter 2025 Financial Results and Provide a Corporate Update on August 7, 2025 - PRNewsWire
- 16 days ago - Trevi Therapeutics to Participate in Upcoming August Conferences - PRNewsWire
- 6 weeks ago - Trevi Therapeutics to Attend Leerink Partners Therapeutics Forum: I&I and Metabolism - PRNewsWire
- 2 months ago - Trevi Therapeutics Announces Closing of $115 Million Underwritten Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares - PRNewsWire
- 2 months ago - Trevi Therapeutics Announces Pricing of $100 Million Underwritten Offering of Common Stock - PRNewsWire
- 2 months ago - Trevi Therapeutics Announces Proposed Public Offering of Common Stock - PRNewsWire